Cited by 426Obsessive-Compulsive Spectrum DisordersPsychoanalysis and Psychopathology ResearchAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

The DOI matches its Crossref record; 227 of the 229 references it cites were found in a registry or an index.

Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment

Open access

Pittenger, Christopher, Bloch, Michael H., Williams, Kyle·2011·Pharmacology & Therapeutics

DOI 10.1016/j.pharmthera.2011.09.006PMC PMC3205262

Open this paper in CoChat — free account

Abstract

Obsessive compulsive disorder is prevalent, disabling, incompletely understood, and often resistant to current therapies. Established treatments consist of specialized cognitive-behavioral psychotherapy and pharmacotherapy with medications targeting serotonergic and dopaminergic neurotransmission. However, remission is rare, and more than a quarter of OCD sufferers receive little or no benefit from these approaches, even when they are optimally delivered. New insights into the disorder, and new treatment strategies, are urgently needed. Recent evidence suggests that the ubiquitous excitatory neurotransmitter glutamate is dysregulated in OCD, and that this dysregulation may contribute to the pathophysiology of the disorder. Here we review the current state of this evidence, including neuroimaging studies, genetics, neurochemical investigations, and insights from animal models. Finally, we review recent findings from small clinical trials of glutamate-modulating medications in treatment-refractory OCD. The precise role of glutamate dysregulation in OCD remains unclear, and we lack blinded, well-controlled studies demonstrating therapeutic benefit from glutamate-modulating agents. Nevertheless, the evidence supporting some important perturbation of glutamate in the disorder is increasingly strong. This new perspective on the pathophysiology of OCD, which complements the older focus on monoaminergic neurotransmission, constitutes an important focus of current research and a promising area for the ongoing development of new therapeutics.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.pharmthera.2011.09.006

Cites

227 of 227 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Oxford University Press eBooks · doi:10.1037/10518-009 · Cited by 19,766
Glutamate uptake
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
The Synaptic Organization of the Brain
(2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195159561.001.1 · Cited by 3,574
The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication
Ruscio, A. M., Stein, D. J., Chiu, W. T., & Kessler, R. C. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.94 · Cited by 2,771
Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites
Robins, L. N. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790210031005 · Cited by 2,550
Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate
Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80086-0 · Cited by 2,534
Animal models of neuropsychiatric disorders
Nestler, E. J., & Hyman, S. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2647 · Cited by 2,023
Brain Lesions, Obesity, and Other Disturbances in Mice Treated with Monosodium Glutamate
Olney, J. (1969) · Science · doi:10.1126/science.164.3880.719 · Cited by 1,885
Genetic enhancement of learning and memory in mice
Tang, Y., Shimizu, E., Dubé, G., Rampon, C., Kerchner, G. A., Zhuo, M., Liu, G., & Tsien, J. Z. (1999) · Nature · doi:10.1038/43432 · Cited by 1,878
Epilepsy and Exacerbation of Brain Injury in Mice Lacking the Glutamate Transporter GLT-1
Tanaka, K., Watase, K., Manabe, T., Yamada, K., Watanabe, M., Takahashi, K., Iwama, H., Nishikawa, T., Ichihara, N., Kikuchi, T., et al. (1997) · Science · doi:10.1126/science.276.5319.1699 · Cited by 1,755
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Hardingham, G. E., & Bading, H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2911 · Cited by 1,644 · cited 6×
“…above, the glutamate transporters play a critical role in terminating excitatory neurotransmission and in regulating extrasynaptic glutamate levels, limiting the activation of extrasynaptic neurotransmitter receptors and consequent excitotoxicity (Danbolt, 2001; Hardingham & Bading, 2010).”
BackgroundInfluential
The glutamate homeostasis hypothesis of addiction
Kalivas, P. W. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2515 · Cited by 1,350
Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: The orbitofronto-striatal model revisited
Menzies, L., Chamberlain, S. R., Laird, A. R., Thelen, S. M., Sahakian, B. J., & Bullmore, E. T. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.09.005 · Cited by 1,190
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Miller, R. G., Mitchell, J. D., & Moore, D. H. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001447.pub3 · Cited by 1,123
A multidimensional model of obsessive-compulsive disorder
Mataix-Cols, D., do Rosario-Campos, M. C., & Leckman, J. F. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.2.228 · Cited by 1,074
Cognitive Enhancers as Adjuncts to Psychotherapy: Use of D-Cycloserine in Phobic Individuals to Facilitate Extinctionof Fear
Ressler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L., & Davis, M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1136 · Cited by 1,063
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
(2008) · APA Practice Guidelines for the Treatment of Psychiatric Disorders: Comprehensive Guidelines and Guideline Watches · doi:10.1176/appi.books.9780890423363.149114 · Cited by 1,028
Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats
Moghaddam, B., & Adams, B. W. (1998) · Science · doi:10.1126/science.281.5381.1349 · Cited by 1,006
Obsessive-compulsive disorder
Abramowitz, J. S., Taylor, S., & McKay, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60240-3 · Cited by 1,002
Sequence Variants in SLITRK1 Are Associated with Tourette's Syndrome
Abelson, J. F., Kwan, K. Y., O'Roak, B. J., Baek, D. Y., Stillman, A. A., Morgan, T. M., Mathews, C. A., Pauls, D. L., Rašin, M.-R., Gunel, M., et al. (2005) · Science · doi:10.1126/science.1116502 · Cited by 940
Distinct Neural Correlates of Washing, Checking, and Hoarding SymptomDimensions in Obsessive-compulsive Disorder
Mataix-Cols, D., Wooderson, S., Lawrence, N., Brammer, M. J., Speckens, A., & Phillips, M. L. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.6.564 · Cited by 929
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Miller, R. G., Jd, M., Lyon, M., & Moore, D. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001447 · Cited by 910
Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder
Radua, J., & Mataix-Cols, D. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.055046 · Cited by 863
Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice
Welch, J. M., Lu, J., Rodriguiz, R. M., Trotta, N. C., Peca, J., Ding, J.-D., Feliciano, C., Chen, M., Adams, J. P., Luo, J., et al. (2007) · Nature · doi:10.1038/nature06104 · Cited by 852
Facilitation of Conditioned Fear Extinction by Systemic Administration or Intra-Amygdala Infusions of d-Cycloserine as Assessed with Fear-Potentiated Startle in Rats
Walker, D. L., Ressler, K. J., Lu, K.-T., & Davis, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02343.2002 · Cited by 815
Subtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major Depression
Sanacora, G., Gueorguieva, R. V., Epperson, C. N., Wu, Y., Appel, M., Rothman, D. L., Krystal, J. H., & Mason, G. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.705 · Cited by 796
Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety
Thomas, A., Burant, A., Bui, N., Graham, D., Yuva-Paylor, L. A., & Paylor, R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1466-y · Cited by 698
Meta-analysis of the symptom structure of obsessive–compulsive disorder
Bloch, M. H., Landeros-Weisenberger, A., Rosario, M. C., Pittenger, C., & Leckman, J. F. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08020320 · Cited by 681
Self-citation
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder
Bloch, M. H., Landeros-Weisenberger, A., Kelmendi, B., Coric, V, Bracken, M. B., & Leckman, J. F. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001823 · Cited by 635
Self-citation
A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder
McDougle, C. J., Epperson, C. N., Pelton, G. H., Wasylink, S., & Price, L. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.794 · Cited by 571
Haloperidol Addition in Fluvoxamine-Refractory Obsessive-Compulsive Disorder
McDougle, C. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040046006 · Cited by 566
Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study
Auer, D. P., Pütz, B., Kraft, E., Lipinski, B., Schill, J., & Holsboer, F. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00159-6 · Cited by 562
Physiology and pharmacology of striatal neurons
Kreitzer, A. C. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135422 · Cited by 530
A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy
Norberg, M. M., Krystal, J. H., & Tolin, D. F. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.012 · Cited by 510
Digging and marble burying in mice: simple methods for in vivo identification of biological impacts
Deacon, R. M. J. (2006) · Nature Protocols · doi:10.1038/nprot.2006.20 · Cited by 508
N-Acetyl Cysteine for Depressive Symptoms in Bipolar Disorder—A Double-Blind Randomized Placebo-Controlled Trial
Berk, M., Copolov, D. L., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Bush, A. I. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.022 · Cited by 500
N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action
Dean, O., Giorlando, F., & Berk, M. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100057 · Cited by 494
Magnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood Disorders
Yüksel, Ç., & Öngür, D. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.016 · Cited by 493
Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse
Aoyama, K., Suh, S. W., Hamby, A. M., Liu, J., Chan, W. Y., Chen, Y., & Swanson, R. A. (2006) · Nature Neuroscience · doi:10.1038/nn1609 · Cited by 484
Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole
Banasr, M., Chowdhury, G. M. I., Terwilliger, R., Newton, S. S., Duman, R. S., Behar, K. L., & Sanacora, G. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.106 · Cited by 458
The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems
van den Heuvel, O. A., Remijnse, P. L., Mataix-Cols, D., Vrenken, H., Groenewegen, H. J., Uylings, H. B. M., van Balkom, A. J. L. M., & Veltman, D. J. (2008) · Brain · doi:10.1093/brain/awn267 · Cited by 454
Glycine binding primes NMDA receptor internalization
Nong, Y., Huang, Y., Ju, W. H., Kalia, L. V., Ahmadian, G., Wang, Y. T., & Salter, M. W. (2003) · Nature · doi:10.1038/nature01497 · Cited by 427
N-Acetylcysteine, a Glutamate Modulator, in the Treatment of Trichotillomania: A Double-blind, Placebo-Controlled Study
Grant, J. E., Odlaug, B. L., & Won Kim, S. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.60 · Cited by 424 · cited 2×
“Subsequently , however, a well-controlled trial showed striking benefit in adult patients with trichotillomania (Grant et al., 2009).”
Background
Cystine/Glutamate Exchange Regulates Metabotropic Glutamate Receptor Presynaptic Inhibition of Excitatory Transmission and Vulnerability to Cocaine Seeking
Moran, M., McFarland, K., Meléndez, R. I., Kalivas, P. W., & Seamans, J. K. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1007-05.2005 · Cited by 412
Hoxb8 Is Required for Normal Grooming Behavior in Mice
Greer, J. M., & Capecchi, M. R. (2002) · Neuron · doi:10.1016/s0896-6273(01)00564-5 · Cited by 401 · cited 1×
“…for repetitive or perseverative behaviors (e.g. Eilam et al., 2006; Joel, 2006; Thomas et al., 2009 ), including grooming (Campbell et al., 1999; Greer & Capecchi, 2002; Welch et al., 2007; Shmelkov et al., 2010); anxietyrelated behaviors (e.g. Welch et al., 2007; Shmelkov et al., 2010);…”
Background
Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disorders
Radua, J., van den Heuvel, O. A., Surguladze, S., & Mataix-Cols, D. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.70 · Cited by 400 · cited 1×
“Morphometric studies have found abnormalities in the same group of brain regions (Menzies et al., 2008; Radua & Mataix-Cols, 2009); increased gray matter volume of the caudate nucleus may be particularly specific for OCD, as opposed to anxiety disorders more generally (Radua et al., 2009).”
Background
A Double-Blind, Placebo-Controlled Study of Memantine in the Treatment of Major Depression
Zarate, C. A., Singh, J. B., Quiroz, J. A., De Jesus, G., Denicoff, K. K., Luckenbaugh, D. A., Manji, H. K., & Charney, D. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.153 · Cited by 387
D-Cycloserine Augmented Exposure Therapy for Obsessive-Compulsive Disorder
Kushner, M. G., Kim, S. W., Donahue, C. B., THURAS, P. D., Adson, D. E., Kotlyar, M., McCabe, J., Peterson, J., & Foa, E. B. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.020 · Cited by 384
Decrease in Caudate Glutamatergic Concentrations in Pediatric Obsessive-Compulsive Disorder Patients Taking Paroxetine
ROSENBERG, D. R., MacMASTER, F. P., KESHAVAN, M. S., FITZGERALD, K. D., STEWART, C. M., & MOORE, G. J. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200009000-00008 · Cited by 377
Obsessive-Compulsive Disorder as a Disturbance of Security Motivation.
Szechtman, H., & Woody, E. Z. (2004) · Psychological Review · doi:10.1037/0033-295x.111.1.111 · Cited by 374
Adults with early-onset obsessive-compulsive disorder
do Rosario-Campos, M. C., Leckman, J. F., Mercadante, M. T., Shavitt, R. G., Prado, H. D. S., Sada, P., Zamignani, D., & Miguel, E. C. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1899 · Cited by 373 · cited 1×
“Childhood-onset and adult-onset OCD may be distinct in important ways (Geller et al., 1998; Rosario-Campos et al., 2001).”
Background
Quality of life for patients with obsessive-compulsive disorder
Koran, L. M., Thienemann, M., & Davenport, R. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.6.783 · Cited by 368
The neural bases of obsessive-compulsive disorder in children and adults
Maia, T. V., Cooney, R. E., & Peterson, B. S. (2008) · Development and Psychopathology · doi:10.1017/s0954579408000606 · Cited by 362 · cited 9×
“The anterior cingulate cortex (ACC), another often-reported node of hyperactivity in OCD (Maia et al., 2008; Menzies et al., 2008; Rotge et al., 2010), has been reported to have decreased Glx in pediatric OCD (Rosenberg et al.”
BackgroundInfluential
Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice
Shmelkov, S. V., Hormigo, A., Jing, D., Proenca, C. C., Bath, K. G., Milde, T., Shmelkov, E., Kushner, J. S., Baljevic, M., Dincheva, I., et al. (2010) · Nature Medicine · doi:10.1038/nm.2125 · Cited by 361
Invasive circuitry-based neurotherapeutics: stereotactic ablation and deep brain stimulation for OCD
Greenberg, B. D., Rauch, S. L., & Haber, S. N. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.128 · Cited by 359
Augmentation of Behavior Therapy With d -Cycloserine for Obsessive-Compulsive Disorder
Wilhelm, S., Buhlmann, U., Tolin, D. F., Meunier, S. A., Pearlson, G. D., Reese, H. E., Cannistraro, P., Jenike, M. A., & Rauch, S. L. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07050776 · Cited by 358
Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder
Arnold, P. D., Sicard, T., Burroughs, E., Richter, M. A., & Kennedy, J. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.769 · Cited by 357
Is Juvenile Obsessive‐Compulsive Disorder a Developmental Subtype of the Disorder? A Review of the Pediatric Literature
GELLER, D. A., Biederman, J., Jones, J. T., PARK, K., SCHWARTZ, S., SHAPIRO, S., & Coffey, B. J. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199804000-00020 · Cited by 344
Glutamatergic Dysfunction in OCD
Chakrabarty, K., Bhattacharyya, S., Christopher, R., & Khanna, S. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300733 · Cited by 344
Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)
Soomro, G. M., Altman, D. G., Rajagopal, S., & Oakley Browne, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001765.pub3 · Cited by 342
An Open-Label Trial of Riluzole in Patients With Treatment-Resistant Major Depression
Zarate, C. A., Payne, J. L., Quiroz, J. A., Sporn, J., Denicoff, K. K., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.171 · Cited by 327
Meta-analysis of the dose-response relationship of SSRI in obsessive–compulsive disorder
Bloch, M. H., McGuire, J., Landeros-Weisenberger, A., Leckman, J. F., & Pittenger, C. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.50 · Cited by 317
Self-citation
Quinpirole induces compulsive checking behavior in rats: A potential animal model of obsessive-compulsive disorder (OCD).
Szechtman, H., Sulis, W., & Eilam, D. (1998) · Behavioral Neuroscience · doi:10.1037/0735-7044.112.6.1475 · Cited by 315
Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: An open-label trial
Coric, V., Taskiran, S., Pittenger, C., Wasylink, S., Mathalon, D. H., Valentine, G., Saksa, J., Wu, Y.-T., Gueorguieva, R., Sanacora, G., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.043 · Cited by 314
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Miller, R. G., Mitchell, J. D., Lyon, M., & Moore, D. H. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001447.pub2 · Cited by 314
N-Acetyl Cysteine, a Glutamate-Modulating Agent, in the Treatment of Pathological Gambling: A Pilot Study
Grant, J. E., Kim, S. W., & Odlaug, B. L. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.021 · Cited by 307
Glial Contribution to Glutamate Uptake at Schaffer Collateral–Commissural Synapses in the Hippocampus
Bergles, D. E., & Jahr, C. E. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-19-07709.1998 · Cited by 302
Kainate receptors: Pharmacology, function and therapeutic potential
Jane, D. E., Lodge, D., & Collingridge, G. L. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.023 · Cited by 293
Extracellular metabolites in the cortex and hippocampus of epileptic patients
Çavuş, I., Kasoff, W. S., Cassaday, M. P., Jacob, R. J., Gueorguieva, R. V., Sherwin, R. S., Krystal, J. H., Spencer, D. D., & Abi‐Saab, W. (2005) · Annals of Neurology · doi:10.1002/ana.20380 · Cited by 292
FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder
Brody, A. L., Saxena, S., Schwartz, J. M., Stoessel, P. W., Maidment, K., Phelps, M. E., & Baxter, L. R. (1998) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(98)00041-9 · Cited by 285
A family study of early-onset obsessive-compulsive disorder
do Rosário, M. C., Leckman, J. F., Cúri, M., Quatrano, S., Katsovitch, L., Miguel, E. C., & Pauls, D. L. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30149 · Cited by 278
Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder
Dickel, D. E., Veenstra-VanderWeele, J., Cox, N. J., Wu, X., Fischer, D. J., Van Etten-Lee, M., Himle, J. A., Leventhal, B. L., Cook, E. H., & Hanna, G. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.778 · Cited by 274
Amino Acid Neurotransmitters Assessed by Proton Magnetic Resonance Spectroscopy: Relationship to Treatment Resistance in Major Depressive Disorder
Price, R. B., Shungu, D. C., Mao, X., Nestadt, P., Kelly, C., Collins, K. A., Murrough, J. W., Charney, D. S., & Mathew, S. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.025 · Cited by 270
Novel Neurotransmitters and Their Neuropsychiatric Relevance
Snyder, S. H., & Ferris, C. D. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.11.1738 · Cited by 263
Obsessive–Compulsive Disorder
Jenike, M. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmcp031002 · Cited by 260
An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression
Zarate, C. A., Quiroz, J. A., Singh, J. B., Denicoff, K. D., Jesus, G. D., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.023 · Cited by 257
Provocation of obsessive–compulsive symptoms: a quantitative voxel-based meta-analysis of functional neuroimaging studies
Rotge, J.-Y., Guehl, D., Dilharreguy, B., Cuny, E., Tignol, J., Bioulac, B., Allard, M., Burbaud, P., & Aouizerate, B. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0838 · Cited by 254
Genome‐wide linkage analysis of families with obsessive‐compulsive disorder ascertained through pediatric probands
Hanna, G. L., Veenstra-VanderWeele, J. M., Cox, N. J., Boehnke, M., Himle, J. A., Curtis, G. C., LEVENTHAL, B. L., & Cook, E. H. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10519 · Cited by 254
Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1
Fumagalli, E. R., Funicello, M., Rauen, T., Gobbi, M., & Mennini, T. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.10.023 · Cited by 248
Reduced Anterior Cingulate Glutamatergic Concentrations in Childhood OCD and Major Depression Versus Healthy Controls
ROSENBERG, D. R., MIRZA, Y., RUSSELL, A., TANG, J., SMITH, J. M., BANERJEE, S. P., BHANDARI, R., ROSE, M., IVEY, J., BOYD, C., et al. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000132812.44664.2d · Cited by 246
Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder
Pittenger, C., Krystal, J. H., & Coric, V. (2006) · NeuroRx · doi:10.1016/j.nurx.2005.12.006 · Cited by 225
Self-citation
The Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infection (PANDAS) Subgroup: Separating Fact From Fiction
Swedo, S. E., Leonard, H. L., & Rapoport, J. L. (2004) · Pediatrics · doi:10.1542/peds.113.4.907 · Cited by 221
In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder
Perani, D., Garibotto, V., Gorini, A., Moresco, R. M., Henin, M., Panzacchi, A., Matarrese, M., Carpinelli, A., Bellodi, L., & Fazio, F. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.04.233 · Cited by 219
Riluzole Enhances Glutamate Uptake in Rat Astrocyte Cultures
Frizzo, M. E., Dall’Onder, L. P., Dalcin, K. B., & Souza, D. O. (2004) · Cellular and Molecular Neurobiology · doi:10.1023/b:cemn.0000012717.37839.07 · Cited by 213
Elevated Cerebrospinal Fluid Levels of Oxytocin in Obsessive-compulsive Disorder: Comparison With Tourette's Syndrome and Healthy Controls
Leckman, J. F. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950100030003 · Cited by 209
Sapap3 and pathological grooming in humans: Results from the OCD collaborative genetics study
Bienvenu, O. J., Wang, Y., Shugart, Y. Y., Welch, J. M., Grados, M. A., Fyer, A. J., Rauch, S. L., McCracken, J. T., Rasmussen, S. A., Murphy, D. L., et al. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30897 · Cited by 207
Clinical features and outcome in dogs and cats with obsessive-compulsive disorder: 126 cases (1989–2000)
Overall, K. L., & Dunham, A. E. (2002) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.2002.221.1445 · Cited by 206
The NMDA Receptor as a Therapeutic Target in Major Depressive Disorder
Pittenger, C., Sanacora, G., & Krystal, J. H. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707780363267 · Cited by 203
Self-citation
Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study
Arnold, P., Rosenberg, D., Mundo, E., Tharmalingam, S., Kennedy, J., & Richter, M. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1847-1 · Cited by 202
D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder
Storch, E. A., Merlo, L. J., Bengtson, M., Murphy, T. K., Lewis, M. H., Yang, M. C., Jacob, M. L., Larson, M., Hirsh, A., Fernandez, M., et al. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32819f8480 · Cited by 200
N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder
Lafleur, D. L., Pittenger, C., Kelmendi, B., Gardner, T., Wasylink, S., Malison, R. T., Sanacora, G., Krystal, J. H., & Coric, V. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0246-6 · Cited by 200
Self-citation
Preliminary Evidence of Riluzole Efficacy in Antidepressant-Treated Patients with Residual Depressive Symptoms
Sanacora, G., Kendell, S. F., Levin, Y., Simen, A. A., Fenton, L. R., Coric, V., & Krystal, J. H. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.037 · Cited by 199
An Open-Label Trial of Riluzole, a Glutamate Antagonist, in Children with Treatment-Resistant Obsessive-Compulsive Disorder
Grant, P., Lougee, L., Hirschtritt, M., & Swedo, S. E. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0021 · Cited by 197
Multiple rare SAPAP3 missense variants in trichotillomania and OCD
Züchner, S., Wendland, J. R., Ashley-Koch, A. E., Collins, A. L., Tran-Viet, K. N., Quinn, K., Timpano, K. C., Cuccaro, M. L., Pericak-Vance, M. A., Steffens, D. C., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.83 · Cited by 196
A Preliminary Study of D-Cycloserine Augmentation of Cognitive-Behavioral Therapy in Pediatric Obsessive-Compulsive Disorder
Storch, E. A., Murphy, T. K., Goodman, W. K., Geffken, G. R., Lewin, A. B., Henin, A., Micco, J. A., Sprich, S. E., Wilhelm, S., Bengtson, M. A., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.07.015 · Cited by 193
A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry
Nordstrom, E. J., & Burton, F. H. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001144 · Cited by 184
Association of the SLC1A1 glutamate transporter gene and obsessive‐compulsive disorder
Stewart, S. E., Fagerness, J. A., Platko, J., Smoller, J. W., Scharf, J. M., Illmann, C., Jenike, E., Chabane, N., Leboyer, M., Delorme, R., et al. (2007) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30533 · Cited by 182
Role of glutamate on T-cell mediated immunity
Pacheco, R., Gallart, T., Lluís, C., & Franco, R. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.01.003 · Cited by 180
Riluzole in the Treatment of Mood and Anxiety Disorders
Pittenger, C., Coric, V., Banasr, M., Bloch, M., Krystal, J. H., & Sanacora, G. (2008) · CNS Drugs · doi:10.2165/00023210-200822090-00004 · Cited by 177
Self-citation
Anti-Brain Autoantibodies and Altered Excitatory Neurotransmitters in Obsessive–Compulsive Disorder
Bhattacharyya, S., Khanna, S., Chakrabarty, K., Mahadevan, A., Christopher, R., & Shankar, S. K. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.77 · Cited by 172
OCD-Like behaviors caused by a neuropotentiating transgene targeted to cortical and limbic D1+ neurons
Campbell, K. M., de Lecea, L., Severynse, D. M., Caron, M. G., McGrath, M. J., Sparber, S. B., Sun, L.-Y., & Burton, F. H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05044.1999 · Cited by 170
Replication Study Supports Evidence for Linkage to 9p24 in Obsessive-Compulsive Disorder
Willour, V. L., Shugart, Y. Y., SAMUELS, J. F., Grados, M. A., Cullen, B., Bienvenu, O. J., Wang, Y., Liang, K., Valle, D. L., Hoehn‐Saric, R., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/423899 · Cited by 170
A Short Echo 1H Spectroscopy and Volumetric MRI Study of the Corpus Striatum in Patients With Obsessive- Compulsive Disorder and Comparison Subjects
Bartha, R., Stein, M. B., Williamson, P., Drost, D. J., Neufeld, R. W. J., Carr, T. J., Canaran, G., Densmore, M., Anderson, G., & Siddiqui, A. R. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1584 · Cited by 168
The neuronal excitatory amino acid transporter EAAC1/EAAT3: does it represent a major actor at the brain excitatory synapse?
Nieoullon, A. L., Canolle, B., Masmejean, F., Guillet, B. A., Pisano, P. S., & Lortet, S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03978.x · Cited by 160
A Single-Blinded Case-Control Study of Memantine in Severe Obsessive-Compulsive Disorder
Stewart, S. E., Jenike, E. A., Hezel, D. M., Stack, D. E., Dodman, N. H., Shuster, L., & Jenike, M. A. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181c856de · Cited by 158
Suicidal Behavior in Obsessive-Compulsive Disorder
Kamath, P., & Reddy, J. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n1114 · Cited by 156
In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders
Rorick‐Kehn, L. M., Johnson, B. G., Knitowski, K. M., Salhoff, C. R., Witkin, J. M., Perry, K. W., Griffey, K. I., Tizzano, J. P., Monn, J. A., McKinzie, D. L., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0758-3 · Cited by 155
1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum
Ebert, D., Speck, O., König, A., Berger, T., Hennig, J., & Hohagen, F. (1997) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(97)00016-4 · Cited by 154
Effects of multiple exposures to d-cycloserine on extinction of conditioned fear in rats
Parnas, A. S., Weber, M. F., & Richardson, R. (2005) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2005.01.001 · Cited by 146
A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder
Wendland, J. R., Moya, P. R., Timpano, K. R., Anavitarte, A. P., Kruse, M. R., Wheaton, M. G., Ren-Patterson, R. F., & Murphy, D. L. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.6 · Cited by 145
Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study
GOFF, D., CATHER, C., GOTTLIEB, J., EVINS, A., WALSH, J., RAEKE, L., OTTO, M., SCHOENFELD, D., & GREEN, M. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.08.012 · Cited by 144
NMDA Receptor Antagonists for the Treatment of Neuropathic Pain
Collins, S., Sigtermans, M. J., Dahan, A., Zuurmond, W. W. A., & Perez, R. S. G. M. (2010) · Pain Medicine · doi:10.1111/j.1526-4637.2010.00981.x · Cited by 143
Reduced Anterior Cingulate Glutamate in Pediatric Major Depression: A Magnetic Resonance Spectroscopy Study
Rosenberg, D. R., MacMaster, F. P., Mirza, Y., Smith, J. M., Easter, P. C., Banerjee, S. P., Bhandari, R. P., Boyd, C. C., Lynch, M. A., Rose, M., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.007 · Cited by 140
Memantine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder
Aboujaoude, E. N., Barry, J. J., & Gamel, N. N. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318192e9a4 · Cited by 138
Open-Label Trial of Riluzole in Generalized Anxiety Disorder
Mathew, S. J., Amiel, J. M., Coplan, J. D., Fitterling, H. A., Sackeïm, H. A., & Gorman, J. M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.12.2379 · Cited by 134
A magnetic resonance spectroscopy investigation of obsessive–compulsive disorder and anxiety
Whiteside, S. P. H., Port, J. D., Deacon, B. J., & Abramowitz, J. S. (2006) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2005.12.006 · Cited by 133
Rituals, stereotypy and compulsive behavior in animals and humans.
Eilam, D., Zor, R., Szechtman, H., & Hermesh, H. (2006) · Neuroscience and Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.08.003 · Cited by 132
Anterior Cingulate Glutamate–Glutamine Levels Predict Symptom Severity in Women With Obsessive–Compulsive Disorder
Yücel, M., Wood, S. J., Wellard, R. M., Harrison, B. J., Fornito, A., Pujol, J., Velakoulis, D., & Pantelis, C. (2008) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670802050546 · Cited by 130
Double-Blind, Placebo-Controlled Trial of Topiramate Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder
Berlin, H. A., Koran, L. M., Jenike, M. A., Shapira, N. A., Chaplin, W. F., Pallanti, S., & Hollander, E. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05266gre · Cited by 129
Predictors of early adult outcomes in pediatric-onset obsessive-compulsive disorder
Bloch, M. H., Craiglow, B. G., Landeros-Weisenberger, A., Dombrowski, P. A., Panza, K. E., Peterson, B. S., & Leckman, J. F. (2009) · Pediatrics · doi:10.1542/peds.2009-0015 · Cited by 129
Self-citation
Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder
Ting, J. T., & Feng, G. (2008) · Current Chemical Genomics · doi:10.2174/1875397300802010062 · Cited by 125
Postpartum-Onset Obsessive-Compulsive Disorder
Uğuz, F., Akman, C., Kaya, N., & Çilli, A. S. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0118 · Cited by 124
Sex, GABA, and nicotine: The impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy
Epperson, C. N., O’Malley, S. S., Czarkowski, K. A., Gueorguieva, R. V., Jatlow, P. I., Sanacora, G., Rothman, D. L., Krystal, J. H., & Mason, G. F. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.09.021 · Cited by 122
On the role of prefrontal cortex glutamate for the antithetical phenomenology of obsessive compulsive disorder and attention deficit hyperactivity disorder
Carlsson, M. L. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(00)00146-9 · Cited by 121
Topiramate augmentation in treatment-resistant obsessive–compulsive disorder: a retrospective, open-label case series
Ameringen, M. V., Mancini, C., Patterson, B. A., & Bennett, M. (2005) · Depression and Anxiety · doi:10.1002/da.20118 · Cited by 121
Familiality of Obsessive-Compulsive Disorder in Nonclinical and Clinical Subjects
Grabe, H. J., Ruhrmann, S., Ettelt, S., Buhtz, F., Hochrein, A., Schulze‐Rauschenbach, S., Meyer, K., Kraft, S., Reck, C., Pukrop, R., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1986 · Cited by 120
Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder
Coric, V., Milanovic, S. M., Wasylink, S., Patel, P., Malison, R. T., & Krystal, J. H. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1396-z · Cited by 118
SIMILAR AND DISSIMILAR MANIFESTATIONS OF OBSESSIVE-COMPULSIVE NEUROSIS IN MONOZYGOTIC TWINS
Inouye, E. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.121.12.1171 · Cited by 118
The caudate nucleus in obsessive–compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study
Hansen, E. S., Hasselbalch, S. G., Law, I. G., & Bolwig, T. G. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002681 · Cited by 114
Differential mRNA expression and protein localization of the SAP90/PSD‐95–associated proteins (SAPAPs) in the nervous system of the mouse
Welch, J. M., Wang, D., & Feng, G. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20060 · Cited by 113
A family‐based association study of the glutamate transporter gene SLC1A1 in obsessive–compulsive disorder in 378 families
Shugart, Y. Y., Wang, Y., Samuels, J. F., Grados, M. A., Greenberg, B. D., Knowles, J. A., McCracken, J. T., Rauch, S. L., Murphy, D. L., Rasmussen, S. A., et al. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30914 · Cited by 112
Selective Depression of Low–Release Probability Excitatory Synapses by Sodium Channel Blockers
Prakriya, M., & Mennerick, S. J. (2000) · Neuron · doi:10.1016/s0896-6273(00)81203-9 · Cited by 108
Association of the serotonin transporter polymorphism and obsessive‐compulsive disorder: Systematic review
Bloch, M. H., Landeros‐Weisenberger, A., Sen, S., Dombrowski, P., Kelmendi, B., Coric, V., Pittenger, C., & Leckman, J. F. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30699 · Cited by 108
Self-citation
Symptom dimensions and subtypes of obsessive-compulsive disorder: a developmental perspective
Leckman, J. F., Bloch, M. H., & King, R. A. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.1/jfleckman · Cited by 108
Self-citation
Dimensional predictors of response to SRI pharmacotherapy in obsessive–compulsive disorder
Landeros‐Weisenberger, A., Bloch, M. H., Kelmendi, B., Wegner, R., Nudel, J., Dombrowski, P. A., Pittenger, C., Krystal, J. H., Goodman, W. K., & Leckman, J. F. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.010 · Cited by 106
Self-citation
Association of the Glutamate Transporter Gene SLC1A1 With Atypical Antipsychotics–Induced Obsessive-compulsive Symptoms
Kwon, J. S., Joo, Y. H., Nam, H. J., Lim, M., Cho, E.-Y., Jung, M. H., Choi, J., Kim, B., Kang, D., Oh, S., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.155 · Cited by 104
Riluzole in psychiatry: a systematic review of the literature
Zarate, C. A., & Manji, H. K. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.9.1223 · Cited by 103
Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice
Shanahan, N. A., Holick Pierz, K. A., Masten, V. L., Waeber, C., Ansorge, M., Gingrich, J. A., Geyer, M. A., Hen, R., & Dulawa, S. C. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.09.026 · Cited by 102
Memantine augmentation for refractory obsessive–compulsive disorder
Pasquini, M., & Biondi, M. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.04.013 · Cited by 100
Use of clomipramine in treatment of obsessive‐compulsive disorder, separation anxiety and noise phobia in dogs: a preliminary, clinical study
Seksel, K., & LINDEMAN, M. (2001) · Australian Veterinary Journal · doi:10.1111/j.1751-0813.2001.tb11976.x · Cited by 98
Memantine for Treatment-Resistant OCD
Poyurovsky, M., Weizman, R., Weizman, A., & Koran, L. M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.2191-a · Cited by 97
On the role of cortical glutamate inobsessive‐compulsive disorder and attention‐deficit hyperactivity disorder, two phenomenologically antithetical conditions
Carlsson, M. L. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.102006401.x · Cited by 96
Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette’s syndrome and obsessive–compulsive disorder
McGrath, M. J., Campbell, K. M., Parks, C. R., & Burton, F. H. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02646-9 · Cited by 95
Effects of glutamate-related drugs on marble-burying behavior in mice: Implications for obsessive–compulsive disorder
Egashira, N., Okuno, R., Harada, S., Matsushita, M., Mishima, K., Iwasaki, K., Nishimura, R., Oishi, R., & Fujiwara, M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.035 · Cited by 95
N-Acetyl Cysteine in the Treatment of Grooming Disorders
Odlaug, B. L., & Grant, J. E. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000264976.86990.00 · Cited by 94
A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity
Starck, G., Ljungberg, M., Nilsson, M. K. L., Jönsson, L., Lundberg, S., Ivarsson, T., Ribbelin, S., EKHOLM, S. E., Carlsson, A., Forssell-Aronsson, E. B., et al. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0045-4 · Cited by 94
Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive-compulsive disorder
Arnold, P. D., MacMaster, F. P., Richter, M. A., Hanna, G. L., Sicard, T., Burroughs, E., Mirza, Y., Easter, P. C., Rose, M., Kennedy, J. L., et al. (2009) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2009.02.005 · Cited by 91
An attractor hypothesis of obsessive–compulsive disorder
Rolls, E. T., Loh, M., & Deco, G. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06379.x · Cited by 91
Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs. Generalized Anxiety Disorder: An Open-Label Trial
Feusner, J. D., Kerwin, L. E., Saxena, S., & Bystritsky, A. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4096 · Cited by 91
A Double-Blind, Placebo-Controlled Trial of Lamotrigine for Pathological Skin Picking
Grant, J. E., Odlaug, B. L., Chamberlain, S. R., & Kim, S. W. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181e617a1 · Cited by 89
Comprehensive family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder
Samuels, J., Wang, Y., Riddle, M. A., Greenberg, B. D., Fyer, A. J., McCracken, J. T., Rauch, S. L., Murphy, D. L., Grados, M. A., Knowles, J. A., et al. (2011) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31184 · Cited by 89
Postmortem analysis of subcortical monoamines and amino acids in Tourette syndrome.
Anderson, G. M., Pollak, E. S., Chatterjee, D., Leckman, J. F., Riddle, M. A., & Cohen, D. J. (1992) · PubMed · Cited by 89
Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder
Delorme, R., Krebs, M., Chabane, N., Roy, I., Millet, B., Mouren-Siméoni, M. C., Maier, W., Bourgeron, T., & Leboyer, M. (2004) · Neuroreport · doi:10.1097/00001756-200403220-00025 · Cited by 88
Brain anatomy and chemistry may predict treatment response in paediatric obsessive--compulsive disorder.
Rosenberg, D., MacMillan, S. N., & Moore, G. J. (2001) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002401 · Cited by 86
Memantine: a comprehensive review of safety and efficacy
Kavirajan, H. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740330802528420 · Cited by 86
Serotonergic Dissection of Obsessive Compulsive Symptoms: A Challenge Study with m-Chlorophenylpiperazine and Sumatriptan
Gross‐Isseroff, R., Cohen, R., Sasson, Y., Voet, H., & Zohar, J. (2004) · Neuropsychobiology · doi:10.1159/000079970 · Cited by 86
Case Study: Caudate Glutamatergic Changes With Paroxetine Therapy for Pediatric Obsessive‐Compulsive Disorder
MOORE, G. J., MACMASTER, F. P., STEWART, C., & ROSENBERG, D. R. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199806000-00017 · Cited by 85
Investigating SAPAP3 variants in the etiology of obsessive-compulsive disorder and trichotillomania in the South African white population
Boardman, L., van der Merwe, L., Löchner, C., Kinnear, C. J., Seedat, S., Stein, D. J., Moolman‐Smook, J. C., & Hemmings, S. M. J. (2010) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2010.05.007 · Cited by 85
Review of the Use of the Glutamate Antagonist Riluzole in Psychiatric Disorders and a Description of Recent Use in Childhood Obsessive-Compulsive Disorder
Grant, P., Song, J. Y., & Swedo, S. E. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.0009 · Cited by 84
Riluzole Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder
Pittenger, C., Kelmendi, B., Wasylink, S., Bloch, M. H., & Coric, V. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181727548 · Cited by 83
Self-citation
Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults
Greenberg, W. M., Benedict, M. M., Doerfer, J., Perrin, M., Panek, L., Cleveland, W. L., & Javitt, D. C. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.10.007 · Cited by 80
Treatment of late-onset OCD following basal ganglia infarct
Carmin, C. N., Wiegartz, P. S., Yunus, U., & Gillock, K. L. (2002) · Depression and Anxiety · doi:10.1002/da.10024 · Cited by 80
Reinforced Spatial Alternation as an Animal Model of Obsessive-Compulsive Disorder (OCD): Investigation of 5-HT2C and 5-HT1D Receptor Involvement in OCD Pathophysiology
Tsaltas, E., Kontis, D., Chrysikakou, S., Giannou, H., Biba, A., Pallidi, S., Christodoulou, A., Maillis, A., & Rabavilas, A. D. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.020 · Cited by 78
The signal attenuation rat model of obsessive–compulsive disorder: a review
Joel, D. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0387-2 · Cited by 78
Annotation: PANDAS: a model for human autoimmune disease
Swedo, S. E., & Grant, P. J. (2004) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2004.00386.x · Cited by 75
Diagnosis and management of compulsive disorders in dogs and cats
Luescher, A. U. (2003) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/s0195-5616(02)00100-6 · Cited by 74
Riluzole Augmentation for Treatment-Resistant Depression
Sanacora, G., Kendell, S. F., Fenton, L. R., Coric, V., & Krystal, J. H. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.2132 · Cited by 72
Sumatriptan, 5-HT1D receptors and obsessive-compulsive disorder
Koran, L. M., Pallanti, S., & Quercioli, L. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00082-7 · Cited by 71
A Novel, Multiple Symptom Model of Obsessive-Compulsive-Like Behaviors in Animals
Andersen, S. L., Greene-Colozzi, E. A., & Sonntag, K. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.05.011 · Cited by 69
Effects of anticonvulsants on veratridine- and KCl-evoked glutamate release from rat cortical synaptosomes
Lingamaneni, R., & Hemmings, H. C. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00810-1 · Cited by 68
Augmentation of Cognitive Behavioral Therapy with Pharmacotherapy
Ganasen, K. A., Ipser, J., & Stein, D. J. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.04.008 · Cited by 68
Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression
Bespalov, A., van Gaalen, M. M., Sukhotina, I. A., Wicke, K. M., Mezler, M., Schoemaker, H., & Groß, G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.089 · Cited by 68
Critical Parameters for d -Cycloserine Enhancement of Cognitive-Behaviorial Therapy for Obsessive-Compulsive Disorder
ROTHBAUM, B. O. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07121871 · Cited by 66
Lamotrigine augmentation in schizophrenia and schizoaffective patients with obsessive-compulsive symptoms
Poyurovsky, M., Glick, I. D., & Koran, L. M. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108099215 · Cited by 65
Serotonin-1D hypothesis of obsessive-compulsive disorder: an update.
Zohar, J., Kennedy, J. L., Hollander, E., & Koran, L. M. (2004) · PubMed · Cited by 63
The glutamate-based genetic immune hypothesis in obsessive-compulsive disorder. An integrative approach from genes to symptoms
Rotgé, J., Aouizerate, B., Tignol, J.-P., Bioulac, B. H., Burbaud, P., & Guehl, D. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.10.043 · Cited by 63
Memantine for non-motor features of Parkinson’s disease: A double-blind placebo controlled exploratory pilot trial
Ondo, W. G., Shinawi, L., Davidson, A. L., & Lai, D. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.12.003 · Cited by 63
Case Study: Caudate Glutamatergic Changes With Paroxetine Persist After Medication Discontinuation in Pediatric OCD
Bolton, J. M., Moore, G. J., MacMillan, S. N., STEWART, C. M., & Rosenberg, D. R. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200108000-00011 · Cited by 62
Topiramate plus paroxetine in treatment-resistant obsessive–compulsive disorder
Hollander, E., & Dell’Osso, B. M. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000199453.54799.cc · Cited by 60
Lamotrigine Augmentation of Serotonin Re-Uptake Inhibitors in Obsessive–Compulsive Disorder
Kumar, T. C. R., & Khanna, S. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2000.0751c.x · Cited by 59
Rapid Resolution of Obsessions After an Infusion of Intravenous Ketamine in a Patient With Treatment-Resistant Obsessive-Compulsive Disorder
Rodriguez, C. I., Kegeles, L. S., Flood, P., & Simpson, H. B. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10l06653 · Cited by 59
Additional support for the association of SLITRK1 var321 and Tourette syndrome
O’Roak, B. J., Morgan, T. M., Fishman, D. O., Saus, E., Alonso, P., Gratacòs, M., Estivill, X., Teltsh, O., Kohn, Y., Kídd, K. K., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.105 · Cited by 59
Association Between Polymorphisms in GRIK2 Gene and Obsessive-Compulsive Disorder: A Family-Based Study
Sampaio, A. S., Fagerness, J. A., Crane, J. N., Leboyer, M., Delorme, R., Pauls, D. L., & Stewart, S. E. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00130.x · Cited by 57
Neurochemical Analyses in Pediatric Obsessive-Compulsive Disorder in Patients Treated With Cognitive-Behavioral Therapy
Benazon, N. R., Moore, G. J., & Rosenberg, D. R. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000087562.01900.de · Cited by 56
Memantine as an Augmenting Agent for Severe Pediatric OCD
HEZEL, D. M., BEATTIE, K., & STEWART, S. E. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08091427 · Cited by 55
Getting a Knack for NAC: N-Acetyl-Cysteine.
Sansone, R. A., & Sansone, L. A. (2011) · PubMed Central · Cited by 54
The Effects of Topiramate Adjunctive Treatment Added to Antidepressants in Patients with Resistant Obsessive-compulsive Disorder
Rubio, G., Jiménez‐Arriero, M. Á., Martínez‐Gras, I., Manzanares, J., & Palomo, T. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000220524.44905.9f · Cited by 52
Fluoxetine treatment of acral lick dermatitis in dogs: A placebo-controlled randomized double blind trial
Wynchank, D., & Berk, M. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)8:1 · Cited by 52
Glycine Transporter-1: A New Potential Therapeutic Target for Schizophrenia
Hashimoto, K., & r (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795049598 · Cited by 51
Lamotrigine as an augmentation agent in treatment-resistant obsessive-compulsive disorder: a case report
Uzun, Ö. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108098809 · Cited by 49
Anxiety in a transgenic mouse model of cortical-limbic neuropotentiated compulsive behavior
McGrath, M. J., Campbell, K. M., Veldman, M. B., & Burton, F. H. (1999) · Behavioural Pharmacology · doi:10.1097/00008877-199909000-00001 · Cited by 49
Pharmacological Enhancement of Behavioral Therapy: Focus on Posttraumatic Stress Disorder
Choi, D. C., ROTHBAUM, B. O., Gerardi, M. A., & Ressler, K. J. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_10 · Cited by 47
Beneficial Effects of the Glutamate-modulating Agent Riluzole on Disordered Eating and Pathological Skin-picking Behaviors
Sasso, D. A., Kalanithi, P. S. A., Trueblood, K. V., Pittenger, C., Kelmendi, B., Wayslink, S., Malison, R. T., Krystal, J. H., & Coric, V. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000245567.29531.d6 · Cited by 47
Self-citation
Brain magnetic resonance spectroscopy in obsessive–compulsive disorder: The importance of considering subclinical symptoms of anxiety and depression
Bédard, M.-J., & Chantal, S. (2011) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2010.10.008 · Cited by 47
A screen of SLC1A1 for OCD‐related alleles
Wang, Y., Adamczyk, A., Shugart, Y. Y., Samuels, J. F., Grados, M. A., Greenberg, B. D., Knowles, J. A., McCracken, J. T., Rauch, S. L., Murphy, D. L., et al. (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31001 · Cited by 47
The NMDA antagonist MK-801 induces hyperalgesia and increases CSF excitatory amino acids in rats: Reversal by guanosine
Schmidt, A. P., Tort, A. B. L., Silveira, P. P., Böhmer, A. E., Hansel, G., Knorr, L., Schallenberger, C., Dalmaz, C., Elisabetsky, E., Crestana, R. H., et al. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.09.009 · Cited by 43

Flagged first, then by citations

2 of the 229 references couldn’t be matched to a known paper.

Sorted by citations

Neuroinflammation and psychiatric illness
Najjar, S., Pearlman, D. M., Alper, K., Najjar, A., & Devinsky, O. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-43 · Cited by 733
Revealing the complex genetic architecture of obsessive–compulsive disorder using meta-analysis
International Obsessive Compulsive Disorder Foundation Genetics Collaborative (IOCDF-GC) and OCD Collaborative Genetics Association Studies (OCGAS) (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.154 · Cited by 618
Repeated cortico-striatal stimulation generates persistent OCD-like behavior
Ahmari, S. E., Spellman, T., Douglass, N. L., Kheirbek, M. A., Simpson, H. B., Deisseroth, K., Gordon, J. A., & Hen, R. (2013) · Science · doi:10.1126/science.1234733 · Cited by 502
Genome-wide association study of obsessive-compulsive disorder
Stewart, S. E., Yu, D., Scharf, J. M., Neale, B. M., Fagerness, J. A., Mathews, C. A., Arnold, P. D., Evans, P. D., Gamazon, E. R., Osiecki, L., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.85 · Cited by 384
Self-citation
Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept
Rodriguez, C. I., Kegeles, L. S., Levinson, A., Feng, T., Marcus, S. M., Vermes, D., Flood, P., & Simpson, H. B. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.150 · Cited by 386

See all 426

Authors: Pittenger, C., Bloch, M. H., & Williams, K.
Affiliations: Yale University (US)
Corresponding author: Pittenger, Christopher
ORCID: Pittenger, Christopher
Bloch, Michael H.
Williams, Kyle
Venue: Pharmacology & Therapeutics
Publisher: Elsevier BV
Published: 2011-12
Volume: 132
Issue: 3
Pages: 314-332
ISSN: 0163-7258 (ISSN-L)
DOI: 10.1016/j.pharmthera.2011.09.006
PMC: PMC3205262
OpenAlex: W2109125813
Cited by: 426
References: 229
Citations by year: 2026: 30 · 2025: 24 · 2024: 23 · 2023: 31 · 2022: 17 · 2021: 33 · 2020: 65 · 2019: 28 · 2018: 25 · 2017: 26 · 2016: 39 · 2015: 34 · 2014: 25 · 2013: 18 · 2012: 7
FWCI: 2.37
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Pharmacology & Therapeutics (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Mental Health (R34MH083115, K08MH081190, K23MH091240, R25MH077823)
Topics: Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords: obsessive-compulsive disorder, glutamate, glutamate dysregulation, treatment-refractory OCD, pathophysiology, excitatory neurotransmission, neuroimaging, animal models, cognitive behavioral therapy, pharmacotherapy
MeSH terms: Animals, Clinical Trials as Topic, Drug Evaluation, Preclinical, Humans, Neurobiology, Obsessive-Compulsive Disorder, Randomized Controlled Trials as Topic, Neurotransmitter Agents, Glutamic Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks